- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01805505
Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound
March 5, 2017 updated by: IVI Madrid
Transabdominal ultrasound guidance is the golden standard for embryo transfers.
Transvaginal ultrasound guidance was proposed recently to provide better visualization and reduce patient discomfort as embryo transfer can be performed with an empty bladder in this case.
The purpose of this study is to determine whether there are any differences between transvaginal and transabdominal ultrasound-guided embryo transfer in terms of ease of use, patient satisfaction, and treatment outcome.
Study Overview
Status
Terminated
Conditions
Study Type
Interventional
Enrollment (Actual)
346
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28023
- IVI Madrid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 49 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients undergoing oocyte donation treatment with transfer of 2 embryos on day 3
Exclusion Criteria:
- Submucous or >3 cm intramural fibroids
- Turner syndrome
- Black recipients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Transvaginal ultrasound-guided embryo transfer
Transvaginal ultrasound-guided transfer of two day-3 embryos
|
Embryo transfer of two day-3 embryos performed with the Kitazato Long ET catheter (Kitazato Medical Co. Ltd., Tokyo, Japan), guided by transvaginal ultrasound
Other Names:
|
Active Comparator: Transabdominal ultrasound-guided embryo transfer
Transabdominal ultrasound-guided transfer of two day-3 embryos
|
Embryo transfer of two day-3 embryos performed with the Cook Soft-Trans ET catheter (Cook Medical Inc., Bloomington, IN, USA), guided by transabdominal ultrasound
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pregnancy rate
Time Frame: At performing the pregnancy test 11 days post-embryo transfer
|
Proportion of patients with a positive pregnancy test
|
At performing the pregnancy test 11 days post-embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical pregnancy rate
Time Frame: At first pregnancy ultrasound (3 weeks post-embryo transfer)
|
Proportion of patients with at least one gestational sac at first pregnancy ultrasound
|
At first pregnancy ultrasound (3 weeks post-embryo transfer)
|
Ongoing pregnancy rate
Time Frame: At 10 weeks post-embryo transfer
|
Proportion of patients with at least one live intrauterine fetus at 10 weeks post-embryo transfer
|
At 10 weeks post-embryo transfer
|
Menstruation-like pain
Time Frame: At embryo transfer
|
Measured on a three-level scale (none/mild/strong)
|
At embryo transfer
|
Discomfort related to vesical distension
Time Frame: At embryo transfer
|
Measured on a three-level scale (none/mild/strong)
|
At embryo transfer
|
Overall discomfort
Time Frame: At embryo transfer
|
Measured on a three-level scale (none/mild/strong)
|
At embryo transfer
|
Difficulty using the assigned technique faced by operators
Time Frame: At embryo transfer
|
Measured on a three-level scale (easy/moderately difficult/very difficult)
|
At embryo transfer
|
Catheterization time
Time Frame: At embryo transfer
|
At embryo transfer
|
|
Conversion to the opposite technique
Time Frame: At embryo transfer
|
Proportion of cases in which embryo transfer was performed using the technique of the opposite randomization arm (i.e., proportion of patients randomized to have transabdominal ultrasound-guided transfer in whom transvaginal ultrasound-guided was performed, and the other way around)
|
At embryo transfer
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Juan A Garcia-Velasco, MD, PhD, IVI Madrid
- Principal Investigator: Erik E Hauzman, MD, PhD, IVI Madrid
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
March 1, 2013
First Submitted That Met QC Criteria
March 4, 2013
First Posted (Estimate)
March 6, 2013
Study Record Updates
Last Update Posted (Actual)
March 7, 2017
Last Update Submitted That Met QC Criteria
March 5, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAD-EH-01-2012-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Transvaginal ultrasound-guided embryo transfer
-
Kasr El Aini HospitalCompleted
-
The University of Hong KongThe University of New South WalesCompleted
-
Fundació Privada EuginCompleted
-
Menoufia UniversityAlexandria UniversityCompleted
-
The University of Hong KongPeking University Third Hospital; Nanfang Hospital of Southern Medical University and other collaboratorsTerminated
-
Cairo UniversityRecruiting
-
University Hospital Virgen de las NievesInstituto de Salud Carlos IIICompletedInfertility | Pregnancy, MultipleSpain
-
Stanford UniversityCompleted
-
IgenomixUnknown
-
National Research Centre, EgyptNot yet recruiting